Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CD44 | P16070 | 1/20 | 0.50 |
| ▸ | MPL | P40238 | 2/20 | 0.39 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.39 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.39 |
| ▸ | PARP1 | P09874 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.37 |
| ▸ | TSHR | P16473 | 3/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | SCN8A | Q9UQD0 | 1/20 | 0.36 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.36 |
| ▸ | AR | P10275 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29512913 | 1.00 | CD44 (0.50) | CD44MPLGABRA1GABRB2PARP1 | |
| SCHEMBL23591999 | 0.84 | CD44 (0.48) | CD44MPLGABRA1GABRB2PARP1 | |
| SCHEMBL396026 | 0.83 | POLB (0.44) | MPLTDP1POLBALDH1A1L3MBTL1 | |
| SCHEMBL5958679 | 0.83 | CD44 (0.46) | CD44MPLGABRA1GABRB2PARP1 | |
| SCHEMBL5958756 | 0.83 | CD44 (0.46) | CD44MPLGABRA1GABRB2PARP1 | |
| SCHEMBL5847428 | 0.81 | CD44 (0.45) | CD44MPLGABRA1GABRB2PARP1 | |
| SCHEMBL30154643 | 0.79 | GABRA1 (0.56) | CD44GABRA1GABRB2TDP1POLB | |
| SCHEMBL1804107 | 0.79 | GABRA1 (0.56) | CD44GABRA1GABRB2TDP1POLB | |
| SCHEMBL14553799 | 0.79 | POLB (0.41) | CD44TDP1POLBALDH1A1TSHR | |
| SCHEMBL5958686 | 0.78 | CD44 (0.42) | CD44GABRA1GABRB2TDP1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 221 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0185128-B1 | CATALYTIC HYDRODESULFURIZATION OF ORTHO-AMINOBENZYL SULFIDES | Monsanto Company (US) | 1990-05-16 | — | — | EP | claimed |
| US-4806687-A | Catalytic hydrodesulfurization of ortho-aminobenzylsulfides | MONSANTO COMPANY (US) | 1989-02-21 | — | — | US | claimed |
| EP-0185128-A1 | Catalytic hydrodesulfurization of ortho-aminobenzyl sulfides | Monsanto Company (US) | 1986-06-25 | — | — | EP | claimed |
| US-4578514-A | Synthesis of sulfilimines | MONSANTO COMPANY (US) | 1986-03-25 | — | — | US | claimed |
| US-4404069-A | Electrolytic desulfurization of anilino sulfur compounds | MONSANTO COMPANY (US) | 1983-09-13 | — | — | US | claimed |
| JP-2045451-A | — | — | None | — | — | JP | disclosed |
| JP-63270632-A | — | — | None | — | — | JP | disclosed |
| JP-63270631-A | — | — | None | — | — | JP | disclosed |
| EP-4724436-A1 | COMPOUNDS AND METHODS FOR MODULATING SPLICING | Remix Therapeutics Inc. (US) | 2026-04-15 | — | — | EP | disclosed |
| EP-4642767-A1 | PYRIMIDINE CARBOXAMIDE COMPOUNDS | Acrivon Therapeutics, Inc. (US) | 2025-11-05 | — | — | EP | disclosed |
| WO-2024259017-A1 | COMPOUNDS AND METHODS FOR MODULATING SPLICING | REMIX THERAPEUTICS INC. (US) | 2024-12-19 | — | — | WO | disclosed |
| US-20240400502-A1 | SULFONYLUREAS AND RELATED COMPOUNDS AND USE OF SAME | UNIV QUEENSLAND (AU) | 2024-12-05 | — | — | US | disclosed |
| US-4297297-A | α-Cyano-β-(substituted-anilino)-N-ethoxycarbonylacrylamide intermediates | ZOECON CORP. (US) | 1981-10-27 | — | — | US | disclosed |
| US-4266056-A | FUNGICIDES, BACTERICIDES | ZOECON CORPORATION (US) | 1981-05-05 | — | — | US | disclosed |
| US-4203920-A | ANTIDIARRHEAL | WILLIAM H. RORER, INC. (US) | 1980-05-20 | — | — | US | disclosed |
| US-4147804-A | ANTIARRHYTHMIA AGENTS | WILLIAM H. RORER, INC. (US) | 1979-04-03 | — | — | US | disclosed |
| US-4132737-A | ENZYME INHIBITORS | ELI LILLY AND COMPANY (US) | 1979-01-02 | — | — | US | disclosed |
| US-4060635-A | Amidinoureas for treating diarrhea | WILLIAM H. RORER, INC. (US) | 1977-11-29 | — | — | US | disclosed |
| US-4046554-A | HERBICIDES | VELSICOL CHEMICAL CORPORATION (US) | 1977-09-06 | — | — | US | disclosed |
| US-3966811-A | HERBICIDES | VELSICOL CHEMICAL CORPORATION (US) | 1976-06-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240400502-A1 | SULFONYLUREAS AND RELATED COMPOUNDS AND USE OF SAME | NLRP3, PYCARD, IAPP | CD44 3283/4885MPL 4002/4885GABRA1 2431/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.